As the world's largest independent blood and plasma donation center operator, ImmunoTek invites the Baton Rouge community to visit the state-of-the-art facility to learn more about plasma donations and how they can positively impact others.
By removing the red and white blood cells from the blood, what remains is the golden liquid called plasma.
Blood-plasma helps create medicines and plasma-based therapies that treat patients with various diseases and disorders, including shock and burn patients, bleeding disorders, transplant patients, those suffering from autoimmune diseases, and many others.
Scientists cannot synthesize blood-plasma, so centers like the new ImmunoTek Plasma in Baton Rouge are vital to keeping up with the worldwide demand for plasma.
The United States provides 2/3 of the world's plasma, and demand increases by 6% - 8% yearly.
To be eligible to donate plasma, in-house medical professionals conduct a medical screening, medical history review, and physical exam.
Donating plasma is much like making a blood donation. A safe, sterile, automated process called plasmapheresis separates plasma from the blood and returns the remaining red blood cells to the donor. Donors can give plasma up to twice a week.
ImmunoTek Plasma's new Baton Rouge location is at 6240 Florida Blvd and will operate Tuesday Saturday.
Walk-in donors are welcome for their first donation; subsequent donations are only by appointment.
Operated by ImmunoTek Bio Centers LLC, ImmunoTek Plasma provides a chance for plasma donors to positively impact the lives of patients who rely on plasma-based therapies while being compensated for their time.
We proudly operate state-of-the-art plasma collection facilities staffed with friendly plasma professionals committed to safety and quality.
ImmunoTek Bio Centers is an independent plasma collection center operator.
ImmunoTek is in developing a reliable plasma supply chain for international biotech companies and partnering with organizations for ancillary projects related to blood-plasma collection.
Since its inception in 2013, ImmunoTek has built and operated more than 70 plasma collection centers, most of which have achieved or are in the process of attaining US FDA licensure and European certification.
ImmunoTek currently has centers operating in 20 states, with 20 additional centers under development and planning underway for more than 40 additional sites over the next three years.
Chemomab secures new patents for CM-101 monoclonal antibody
argenx receives FDA priority review for VYVGART Hytrulo in CIDP
Diamyd Medical granted US FDA Fast Track designation for Diamyd diabetes treatment
Ono partners with Shattuck Labs for bifunctional fusion proteins
Artax Biopharma doses first subject in AX-158 Phase 2a psoriasis trial
Innovent Biologics announces CFO transition
Bio-Thera Solutions commences dosing in BAT6026 Phase IA/IIB clinical trial
BioSenic expands patent coverage for ATO therapeutic platform
Celltrion USA submits CT-P47 Biologics License Application to FDA
NS Pharma's NS-229 receives European Commission orphan drug designation
Kyverna Therapeutics' KYV-101 granted US FDA fast track designation
InnoCare Pharma receives U.S. FDA clearance for ICP-248 clinical trial